The Next Big Thing | GenomeWeb

The Next Big Thing

There was once a time that researchers had to be convinced that molecular population genetics was useful, says Mike the Mad Biologist. Once the field became popular, the "early adopters" who were regularly using PCR and clone-based sequences were "hot intellectual commodities" — that is until the field became overcrowded, and nearly every department already had a molecular population geneticist. A few years before that, Mike says, there was a similar phenomenon in marine biology with clonal invertebrate biologists. So which niche is next?

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.